FK506 ameliorates renal injury in early experimental diabetic rats induced by streptozotocin

International Immunopharmacology

Volumn 11, Issue 10, 2011, Pages 1613-1619

  Qi, Xiang Ming ^a   Wu, Yong Gui ^a   Liang, Chao ^a   Zhang, Pei ^a   Dong, Jing ^a   Ren, Ke Jun ^a   Zhang, Wei ^a   Fang, Fang ^a   Shen, Ji Jia ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Smooth muscle actin; Calcineurin; Diabetic nephropathy; FK506; Transforming growth factor 1

Indexed keywords

ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; CALCINEURIN; COLLAGEN TYPE 4; CYCLOSPORIN A; OSTEOPONTIN; SYNAPTOTAGMIN I; TACROLIMUS; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG MECHANISM; INTERSTITIAL NEPHRITIS; KIDNEY MASS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; URINARY EXCRETION; WESTERN BLOTTING;

ACTINS; ADMINISTRATION, ORAL; ANIMALS; CALCINEURIN; COLLAGEN TYPE IV; CYTOSKELETAL PROTEINS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; GTPASE-ACTIVATING PROTEINS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; NEOPLASM PROTEINS; NUCLEAR PROTEINS; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; RATS; RATS, INBRED STRAINS; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 80053234606     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.05.023     Document Type: Article

References (35)

1. H.E. Abboud Growth factors and diabetic nephropathy: an overview Kidney Int 52 1997 S2 S6
2. G. Wolf, and F.N. Ziyadeh Molecular mechanisms of diabetic renal hypertrophy Kidney Int 56 1999 393 405 (Pubitemid 29353136)
3. J.L. Gooch, Y. Tang, J.M. Ricono, and H.E. Abboud Insulin-like growth factor-I (IGF-I) induces renal hypertrophy via a calcineurin-dependent mechanism J Biol Chem 276 2001 42492 42500
4. J.L. Gooch, Y. Gorin, B.X. Zhang, and H.E. Abboud Involvement of calcineurin in transforming growth factor-β mediated regulation of extracellular matrix accumulation J Biol Chem 279 2000 15561 15570 (Pubitemid 38618957)
5. J.L. Gooch, Y. Gorin, and Y. Tang TGFβ-mediated activation of Erk1/Erk2 and induction of ECM synthesis is associated with activation of calcineurin phosphatase and generation of reactive oxygen species (ROS) J Am Soc Nephrol 12 2001 591A
6. J.L. Gooch, J.L. Barnes, S. Garcia, and H.E. Abboud Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation Am J Physiol - Renal 284 2003 144 154
7. M.D. Tharp Calcineurin inhibitors Dermatol Ther 15 2002 325 332 (Pubitemid 36133860)
8. E.R. Weibel Stereological methods: practical methods for biological morphometry 1979 Academic Press London pp 162-203
9. M.M. Bradford A rapid and sensitive method of the quantification of microgram quantities of protein utilizing the principle of protein dye binding Anal Biochem 72 1976 248 254
10. Y.G. Wu, K.J. Ren, C. Liang, L. Yuan, X.M. Qi, and J. Dong Renoprotective effect of total glucosides of paeony (TGP) and its mechanism in experimental diabetes J Pharmacol Sci 109 2009 78 87
11. Y.G. Wu, J. Dong, L. Yuan, C. Liang, K.J. Ren, and W. Zhang Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy Cytokine 44 2008 85 91
12. K. Yozai, K. Shikata, M. Sasaki, A. Tone, S. Ohga, and H. Usui Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions J Am Soc Nephrol 16 2005 3326 3338 (Pubitemid 46179336)
13. Y. Kikuchi, T. Imakiire, M. Yamada, T. Saigusa, T. Hyodo, and N. Hyodo Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats Nephrol Dial Transplant 20 2005 1573 1581 (Pubitemid 41418579)
14. A. Tone, K. Shikata, M. Sasaki, S. Ohga, K. Yozai, and Nishishita Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats Diabetologia 8 2005 2402 2411 (Pubitemid 41618933)
15. A. Rivero, C. Mora, M. Muros, J. García, H. Herrera, and J.F. Navarro-González Pathogenic perspectives for the role of inflammation in diabetic nephropathy Clin Sci (Lond) 116 2009 479 492
16. N. Lloberas, J.M. Cruzado, M. Franquesa, I. Herrero-Fresneda, J. Torras, and G. Alperovich Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats J Am Soc Nephrol 17 2006 1395 1404 (Pubitemid 43673420)
17. S. Wittmann, C. Daniel, A. Stief, R. Vogelbacher, K. Amann, and C. Hugo Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat Transplantation 87 2009 1290 1299
18. M. Buttini, S. Limonta, M. Luyten, and Boddeke Distribution of calcineurin A isoenzyme mRNAs in rat thymus and kidney Histochem J 27 1995 291 299
19. H. Mukai, T. Kuno, C. Chang, B. Lane, J. Luly, and C. Tanaka FKBP-12-FK506 complex inhibits phosphatase activity in two mammalian isoforms of calcineurin irrespective of their substrates or activation mechanisms J Biochem (Tokyo) 113 1993 292 298 (Pubitemid 23100169)
20. J. Tumlin Expression and function of calcineurin in the mammalian nephron: physiological roles, receptor signaling and ion transport Am J Kidney Dis 30 1997 884 895 (Pubitemid 27524356)
21. F. Rusnak, and P. Mertz Calcineurin-form and function Physiol Rev 80 2000 1483 1521
22. A. Musaro, K.J. McCullagh, F.J. Naya, E.N. Olsen, and N. Rosenthal IGF-I induces skeletal myocyte hypertrophy in association with GATA-2 and NF-ATc1 Nature 400 1999 581 585 (Pubitemid 29381809)
23. 2+-dependent calcineurin signaling pathway Nature 400 1999 576 580
24. G.R. Crabtree Calcium, calcineurin and the control of transcription J Biol Chem 276 2000 2313 2316
25. S. Schreiber, and B.R. Crabtree The mechanism of action of cyclosporine A and FK506 Immunol Today 13 1992 136 142
26. J. Molkentin Calcineurin and beyond: cardiac hypertrophic signaling Circ Res 87 2000 731 738
27. Y. Liu Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention J Am Soc Nephrol 15 2004 1 12 (Pubitemid 38020692)
28. J.M. Fan, Y.Y. Ng, P.A. Hill, D.J. Nikolic-Paterson, W. Mu, and R.C. Atkins Transforming growth factor-beta regulates epithelial-myofibroblast transdifferentiation in vitro Kidney Int 56 1999 1455 1467 (Pubitemid 29451252)
29. J.H. Yang, F.L. Zheng, H. Wu, Z. Su, L. Duan, and Y. Li Effects of FK506 on transdifferentiation and NF-κB activity of human tubular cells induced by TGF-β in vitro J Nephrol Dialy Transplant 13 2004 124 128
30. D.T. Denhardt, M. Noda, A.W.O. O'Regan, D. Pavlin, and J.S. Berman Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival J Clin Invest 107 2001 1055 1061 (Pubitemid 32422899)
31. C. Li, C.W. Yang, C.W. Park, H.J. Ahn, W.Y. Kim, and K.H. Yoon Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats Kidney Int 63 2003 454 463 (Pubitemid 36126792)
32. T.J. Hsieh, R. Chen, M.L. Brezniceanu, F. Liu, M.L. Brezniceanu, and C.I. Whiteside Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling Kidney Int 69 2006 1005 1015 (Pubitemid 43372175)
33. S. Philip, and G.C. Kundu Osteopontin induces nuclear factor κB-mediated promatrix metalloproteinase-2 activation through IκBα/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways J Biol Chem 278 2003 14487 14497 (Pubitemid 36800002)
34. S. Philip, A. Bulbule, and G.C. Kundu Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through Nuclear Factor-κB-mediated induction of membrane Type 1 matrix metalloproteinase in murine melanoma cells J Biol Chem 276 2001 44926 44935
35. Y.T. Wong, D.R.M. Jaques, J.A.M. Shaw, and D. Talbot Audit of diabetes in a renal transplant population Transplant Proc 37 2005 3283 3285 (Pubitemid 41659865)